Progressive Muscle Relaxation Training in Post-traumatic Stress Disorder in Disasters

NCT ID: NCT07164261

Last Updated: 2025-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-02

Study Completion Date

2026-09-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to investigate the effectiveness of progressive muscle relaxation training in disaster victims experiencing post-traumatic stress disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Post-traumatic stress disorder (PTSD) is an often devastating psychiatric condition that can occur in people who experience or witness a traumatic event.The estimated lifetime prevalence of PTSD is reported to be 6.8%.While trauma-focused psychotherapy is generally the first-line treatment in PTSD management, pharmacological treatments (selective serotonin reuptake inhibitors) are recommended in second-line treatment.Additionally, various physiotherapy and rehabilitation approaches such as aerobic, respiratory, relaxation, stretching, balance and strengthening exercises can also be used.Progressive muscle relaxation training increases parasympathetic nervous system activity. This is said to reduce anxiety and stress levels and improve sleep quality, resulting in physical and mental relaxation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The individuals will be divided into two groups: PGDI and Control groups using block randomization.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PKGE GROUP

Progressive muscle relaxation training will be given additionally to individuals in the PKGE group.

Group Type EXPERIMENTAL

progressive muscle relaxation training

Intervention Type OTHER

Progressive muscle relaxation training will be performed twice a week, each session lasting 20-30 minutes, for a total of 12 sessions over 6 weeks.

CONTROL GROUP

Individuals in the control group will continue their standard treatment.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

progressive muscle relaxation training

Progressive muscle relaxation training will be performed twice a week, each session lasting 20-30 minutes, for a total of 12 sessions over 6 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals affected by disasters
* Those diagnosed with PTSD according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria
* Aged 18-65 will be included

Exclusion Criteria

* Individuals with uncontrolled comorbidities accompanying PTSD (such as diabetes or hypertension)
* serious psychological disorders (such as dementia, psychosis/manic episodes)
* musculoskeletal conditions that would interfere with exercise training
* received PKGE training within the last year
* pregnant
* have substance abuse
* have communication difficulties, and are unable to use technology for telerehabilitation will not be included in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bitlis Eren University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mesut Arslan

assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bitlis Eren Universty

Bitlis, Bitlis /merkez, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tuğba karadaşlı

Role: CONTACT

05376059436

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

tuğba karadaşlı

Role: primary

05376059436

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

tssb-kgee

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.